Expert Safety Testing to Accelerate Your Cell Therapy Development
May 11, 2012 - Charles River's unique portfolio of services, including discovery, preclinical, biopharmaceutical testing, cell detection methods, specialized and unique models, and regulatory guidance, provides the full spectrum of resources needed to conduct a successful cell therapy safety program.
Custom Study Designs
Charles River assists clients in developing cellular therapies using a strategic and consultative approach. With great consideration given to regulatory expectations, our customized cellular therapy programs integrate both safety and efficacy endpoints as well as mitigate risk factors inherent to developing novel cellular therapies. In the design of your program, our multidisciplinary team will incorporate the novel properties of your cellular product, including considerations of cross-species reactivity, animal model selection and development of validated translational biomarkers.
For more information about how Charles River can support and accelerate your cell therapy development, please contact us at askcharlesriver@crl.com.
Related Information